Company Filing History:
Years Active: 1999-2002
Title: Innovator Profile: Lisa M. Schultze from San Carlos, CA
Introduction
Lisa M. Schultze, an accomplished inventor based in San Carlos, California, is recognized for her significant contributions to the field of pharmaceuticals through her innovative work related to nucleotide analog compositions. With two patents to her name, Lisa exemplifies the spirit of research and development in the biotechnology sector.
Latest Patents
One of Lisa's latest patents focuses on "Nucleotide Analog Compositions," which provides crystalline forms of adefovir dipivoxil alongside methods to prepare these crystals. This invention holds substantial potential for large-scale synthesis, ensuring that adefovir dipivoxil can be formulated into therapeutic dosages effectively. Notably, the invention includes an anhydrous crystal form of adefovir dipivoxil, demonstrating Lisa's commitment to advancing pharmaceutical science.
Her second patent, "Nucleotide Analog Composition and Synthesis Method," introduces a composition comprising bis(POC)PMPA and fumaric acid (in a 1:1 ratio). This innovative composition serves as an essential intermediate for preparing antiviral compounds and can be administered to patients for antiviral therapy or prophylaxis, especially through oral intake. Furthermore, the patent details methods for synthesizing PMPA and its intermediates, emphasizing a reaction that produces diethyl PMPA with an improved by-product profile compared to previous methods.
Career Highlights
Lisa has built her career at Gilead Sciences, Inc., a leading company in the biopharmaceutical industry, known for its focus on research and development of antiviral drugs. Her work at Gilead not only highlights her scientific expertise but also underlines her role in advancing significant medical therapies.
Collaborations
Working closely with talented colleagues like John D. Munger and John C. Rohloff, Lisa has participated in collaborative efforts that enhance her research and drive innovation. These partnerships reflect a culture of teamwork and shared goals within the scientific community, contributing to breakthroughs that have the potential to impact patient care positively.
Conclusion
Lisa M. Schultze represents a key figure in the realm of biotechnology, with her patents presenting novel solutions to the challenges in antiviral therapies. Her contributions at Gilead Sciences are indicative of her dedication to innovation and the betterment of healthcare through science. As an inventor, Lisa continues to inspire future generations in the field of pharmaceuticals.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.